SPONSOR
Beijing Mabworks Biotech Co., Ltd.
Total Trials
4
Recruiting
4
Phases
Phase 1, Phase 2, Phase 1
Conditions studied: Follicular Lymphoma and Marginal Zone LymphomaAdvanced or Metastatic Solid TumorHER2-positive Recurrent or Metastatic Malignant Solid TumorNon-Hodgkin's Lymphoma
NCT04110301 Phase 1, Phase 2
Recruiting
MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL)
Follicular Lymphoma and Marginal Zone Lymphoma
NCT04965077 Phase 1
Recruiting
Treatment of Advanced and Metastatic Solid Tumors With MIL97
Advanced or Metastatic Solid Tumor
NCT03842085 Phase 1
Recruiting
Phase I Clinical Study of MBS301 in Treatment of HER2 Positive Recurrent or Metastatic Malignant Solid Tumor
HER2-positive Recurrent or Metastatic Malignant Solid Tumor
NCT05806099 Phase 1, Phase 2
Recruiting
A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHL
Non-Hodgkin's Lymphoma